Position in HIMS
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$2,780,984
+$453,243 QoQ
Shares Held
80,213
+11.9% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#126
of 504 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Derivatives in HIMS
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$628,110
PutShares
12,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DAVENPORT & Co LLC holds $9,815,900 across 6 Drug Manufacturers - Specialty & Generic names. HIMS ranks #1 (28.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
This page
|
80,213 | $2,780,984 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
80,284 | $2,720,021 | |
| 3 | HLN |
Haleon plc
|
244,030 | $2,276,799 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
25,394 | $1,200,374 | |
| 5 | ZTS |
Zoetis Inc.
|
9,125 | $655,722 | |
| 6 | SIGA |
Siga Technologies Inc
|
50,000 | $182,000 |
All Filings in HIMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,780,984 | 80,213 | Shares | Sole | 2026-07-13 | |
| 2025-12-31 | $2,327,741 | 71,689 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $4,095,013 | 72,197 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $628,110 | 12,600 | Put | Sole | 2025-07-22 | |
| 2025-06-30 | $3,563,926 | 71,493 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $2,116,607 | 71,628 | Shares | Sole | 2025-04-28 | |
| 2025-03-31 | $206,850 | 7,000 | Put | Sole | 2025-04-28 | |
| No filing history on record for this holder in this stock. | ||||||